DE60012554D1 - Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit - Google Patents

Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Info

Publication number
DE60012554D1
DE60012554D1 DE60012554T DE60012554T DE60012554D1 DE 60012554 D1 DE60012554 D1 DE 60012554D1 DE 60012554 T DE60012554 T DE 60012554T DE 60012554 T DE60012554 T DE 60012554T DE 60012554 D1 DE60012554 D1 DE 60012554D1
Authority
DE
Germany
Prior art keywords
barreness
endometriosis
bzw
treatment
beta agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60012554T
Other languages
English (en)
Other versions
DE60012554T2 (de
Inventor
William J Bologna
Dominique De Ziegler
Howard L Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia Laboratories Bermuda Ltd
Original Assignee
Columbia Laboratories Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories Bermuda Ltd filed Critical Columbia Laboratories Bermuda Ltd
Application granted granted Critical
Publication of DE60012554D1 publication Critical patent/DE60012554D1/de
Publication of DE60012554T2 publication Critical patent/DE60012554T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE60012554T 1999-10-05 2000-10-04 Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit Expired - Lifetime DE60012554T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US157754P 1999-10-05
US66838400A 2000-09-25 2000-09-25
US668384 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en) 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility

Publications (2)

Publication Number Publication Date
DE60012554D1 true DE60012554D1 (de) 2004-09-02
DE60012554T2 DE60012554T2 (de) 2005-11-24

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60012554T Expired - Lifetime DE60012554T2 (de) 1999-10-05 2000-10-04 Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Country Status (28)

Country Link
EP (1) EP1220667B1 (de)
JP (2) JP2003510354A (de)
KR (1) KR100738724B1 (de)
CN (1) CN1218694C (de)
AR (1) AR028487A1 (de)
AT (1) ATE271860T1 (de)
AU (1) AU780736B2 (de)
BR (1) BR0014548A (de)
CA (1) CA2385974C (de)
CO (1) CO5251423A1 (de)
DE (1) DE60012554T2 (de)
DK (1) DK1220667T3 (de)
ES (1) ES2223581T3 (de)
GE (1) GEP20043313B (de)
HK (1) HK1044120B (de)
HU (1) HU225990B1 (de)
IL (2) IL148784A0 (de)
MA (1) MA25501A1 (de)
MX (1) MXPA02003453A (de)
MY (1) MY129518A (de)
NO (1) NO329663B1 (de)
NZ (1) NZ518429A (de)
PE (1) PE20010742A1 (de)
PT (1) PT1220667E (de)
TR (1) TR200200899T2 (de)
TW (1) TWI280877B (de)
UA (1) UA74168C2 (de)
WO (1) WO2001024788A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (de) 2006-06-29 2008-01-02 Polichem S.A. Verwendung einer hydrophilen Matrix, die ein Polyacrylsäurederivat, einen Celluloseether und ein Zerfallsmittel enthält, für die Herstellung eines Medikamentes zur Behandlung weiblicher Genitalstörungen
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
KR102166867B1 (ko) * 2010-03-22 2020-10-19 앨러간 파마슈티컬스 인터내셔널 리미티드 항프로게스틴의 비독성 전달을 위한 조성물들과 그 방법들
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
ES2701400T3 (es) 2012-05-31 2019-02-22 Repros Therapeutics Inc Formulaciones para la administración vaginal de antiprogestinas
EP2914268B1 (de) 2012-11-02 2018-07-04 Repros Therapeutics Inc. Verfahren und zusammensetzungen zur behandlung von progesteronbedingten zuständen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
CO5251423A1 (es) 2003-02-28
IL148784A (en) 2006-12-31
WO2001024788A2 (en) 2001-04-12
NO329663B1 (no) 2010-11-29
TR200200899T2 (tr) 2002-07-22
CA2385974C (en) 2010-01-26
EP1220667A2 (de) 2002-07-10
MY129518A (en) 2007-04-30
UA74168C2 (uk) 2005-11-15
HU225990B1 (en) 2008-02-28
AU780736B2 (en) 2005-04-14
KR100738724B1 (ko) 2007-07-12
BR0014548A (pt) 2002-06-04
ES2223581T3 (es) 2005-03-01
TWI280877B (en) 2007-05-11
IL148784A0 (en) 2002-09-12
HK1044120A1 (en) 2002-10-11
MXPA02003453A (es) 2002-08-20
PT1220667E (pt) 2004-11-30
DE60012554T2 (de) 2005-11-24
AU7525000A (en) 2001-05-10
CA2385974A1 (en) 2001-04-12
NZ518429A (en) 2004-02-27
HK1044120B (zh) 2004-12-17
JP2010018639A (ja) 2010-01-28
CN1218694C (zh) 2005-09-14
HUP0203050A2 (hu) 2003-02-28
CN1377264A (zh) 2002-10-30
JP2003510354A (ja) 2003-03-18
DK1220667T3 (da) 2004-12-06
PE20010742A1 (es) 2001-07-19
AR028487A1 (es) 2003-05-14
MA25501A1 (fr) 2002-07-01
HUP0203050A3 (en) 2006-02-28
WO2001024788A3 (en) 2001-12-06
NO20021591L (no) 2002-05-28
GEP20043313B (en) 2004-03-10
EP1220667B1 (de) 2004-07-28
ATE271860T1 (de) 2004-08-15
KR20020062285A (ko) 2002-07-25
NO20021591D0 (no) 2002-04-04

Similar Documents

Publication Publication Date Title
ATE250575T1 (de) Ep4 rezeptor selektive agonisten zur behandlung der osteoporose
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE60020820D1 (de) Thiadiazolyl-harnstoffe oder -thioharnstoffe zur antiviralen behandlung
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
DE69931975D1 (de) FSH Mimetika zur Behandlung von Infertilität
DE60039415D1 (de) Reovirus zur behandlung von zellulären proliferativen erkrankungen
DE69912972D1 (de) Antibiotische zusammensetzungen zur behandlung des auges
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69819515D1 (de) Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
DE60031790D1 (de) Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
DE60012554D1 (de) Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit
MXPA03004303A (es) DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR.
DE59707096D1 (de) Haarbehandlungsmittel zur Festigung der Haare
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
ATE250580T1 (de) Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
DE69918042D1 (de) Verfahren zur Behandlung keramischer Oberflächen

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1220667

Country of ref document: EP

Representative=s name: TERGAU & WALKENHORST PATENT- UND RECHTSANWAELTE, 9